A clinical trial of levamisole in primary biliary cirrhosis
- PMID: 6763217
- PMCID: PMC2426569
- DOI: 10.1136/pgmj.58.685.701
A clinical trial of levamisole in primary biliary cirrhosis
Abstract
A small pilot study of levamisole in primary biliary cirrhosis failed to demonstrate any improvement in liver function and immunological abnormalities even in 'early' cases. This may be due to the fact that the defect in the immune system lies in its afferent arm. At present, levamisole, which is potentially toxic, cannot be recommended in conventional doses for the treatment of this disease.
Similar articles
-
The treatment of primary biliary cirrhosis.J Clin Hosp Pharm. 1986 Apr;11(2):65-73. doi: 10.1111/j.1365-2710.1986.tb00830.x. J Clin Hosp Pharm. 1986. PMID: 3519687 Review. No abstract available.
-
Colchicine in primary biliary cirrhosis.Aliment Pharmacol Ther. 1991 Aug;5(4):321-9. doi: 10.1111/j.1365-2036.1991.tb00035.x. Aliment Pharmacol Ther. 1991. PMID: 1777543 Review.
-
Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.Hepatology. 2002 Feb;35(2):258-62. doi: 10.1053/jhep.2002.31607. Hepatology. 2002. PMID: 11826397 Review. No abstract available.
-
Ursodeoxycholic acid and primary biliary cirrhosis.BMJ. 1994 Aug 20-27;309(6953):491-2. doi: 10.1136/bmj.309.6953.491. BMJ. 1994. PMID: 8086896 Free PMC article. No abstract available.
-
Treatment of primary biliary cirrhosis.Semin Liver Dis. 1985 Aug;5(3):228-40. doi: 10.1055/s-2008-1040620. Semin Liver Dis. 1985. PMID: 3901272 Review. No abstract available.
Cited by
-
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011648. doi: 10.1002/14651858.CD011648.pub2. Cochrane Database Syst Rev. 2017. PMID: 28350426 Free PMC article.
-
New directions in primary biliary cirrhosis.BMJ. 1990 Dec 8;301(6764):1290-1. doi: 10.1136/bmj.301.6764.1290. BMJ. 1990. PMID: 2271850 Free PMC article. No abstract available.